Cervical Length Pre-induction as a Tool to Predict Vaginal Birth

Use of Cervical Length Previous to the Use of Prostaglandins as a Tool to Predict Vaginal Birth in Pregnancies With > 41 Weeks Gestation.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02916082

Enrollment

200

Registered

2016-09-27

Start date

2015-11-30

Completion date

2016-08-31

Last updated

2016-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Length Measurement, Pregnancy, Prolonged

Keywords

Cervical length, Prolonged pregnancy, Vaginal birth

Brief summary

To evaluate the value of measuring cervical length as a predictor of vaginal birth after induction of labor with prostaglandins in pregnancies with 41 weeks of gestation.

Interventions

PROCEDURECervical length measurement

Vaginal ultrasound to measure cervical length previous to use of prostaglandins.

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* 41 weeks or more of gestational age * Cervical length measured by a FMF certified physician

Exclusion criteria

* Any condition that could interfere with a possible vaginal birth (previous cesarean section, hypertensive disorders of pregnancies).

Design outcomes

Primary

Measure	Time frame	Description
Vaginal Birth	72 hours	Number of vaginal births obtained after a measure of cervical length below 2,5 cms.

Secondary

Measure	Time frame	Description
Induction to delivery time	72 hours	Time (hours) between the application of a prostaglandin and termination of pregnancy (vaginal or cesarean).

Countries

Panama

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026